Licensed vaccine
Menactra
FDA-licensed vaccine · Sanofi Pasteur Inc · STN 125089
Key facts
| Trade name | Menactra |
|---|---|
| Proper name | Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine |
| Manufacturer | Sanofi Pasteur Inc |
| Submission tracking number (STN) | 125089 |
| FDA product areas | Biologics |
| Recent FDA documents | April 27, 2018 Approval Letter - Menactra, Package Insert - Menactra, Supporting Documents older than three years - Menactra |
| FDA page updated | Nov 19, 2019 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: